Haftungsausschluss: Diese Website bündelt öffentlich verfügbare Daten aus offiziellen Quellen wie FDA, ClinicalTrials.gov, PubMed und SEC EDGAR nur zur allgemeinen Information. Sie stellt keine medizinische Beratung, Diagnose, Behandlungsempfehlung oder Anlageberatung dar.

PubMed

Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study.

PMID: 33008462 ·

A, l, m, i, r, , B, a, d, n, j, e, v, i, ć, ;, , L, e, j, l, a, , G, u, r, b, e, t, a, , P, o, k, v, i, ć, ;, , Z, i, j, a, d, , D, ž, e, m, i, ć, ;, , F, a, h, i, r, , B, e, č, i, ć

ZeitschriftBiomedical engineering online
Jahr
PMID33008462

Zusammenfassung

The world is facing an unprecedented outbreak affecting all aspects of human lives which is caused by the COVID-19 pandemic. Due to the virus novelty, healthcare systems are challenged by a high rate of patients and the shortage of medical products. To address an increased need for essential medical products, national authorities, worldwide, made various legislative concessions. This has led to essential medical products being produced by automotive, textile and other companies from various indu

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.

↑